Log In
Print this Print this

subtype-selective Nav1.7 compound

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSubtype-selective compound targeting Nav1.7 (SCN9A)
Molecular Target Nav1.7 (SCN9A)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today